Lilly Stock Enters 'Sell in May' Territory Amid Looming Pricing Pressures

Lilly's stock has bounced into what is considered 'Sell in May' territory, indicating potential market caution. This movement comes as the company faces looming pricing pressures, which could impact its future performance.